Molecular Testing in Metastatic Gastric/GEJ Cancer
3 意见
• 06/30/23
0
0
嵌入
David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论